Recent advances in immunotherapy have led to the development of NK cell-based cancer treatments that aim to harness the potential of these cells to kill cancer cells. NK cells can be isolated from the patient's blood or from a donor and expanded in the laboratory before being infused back into the patient. This approach, known as adoptive NK cell therapy, has shown promising results in clinical...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian